the company completed the elimination of certain corporate redundancies , the planning of country consolidation activities and the renegotiating of supply contracts with vendors . additionally , the company initiated reorganization activities that include manufacturing and logistics . the company achieved tax savings as it realized complementary tax attributes of the combined businesses . with regard to revenue synergies , dentsply sirona launched combined commercial activities , such as bundling products and developing cross-selling opportunities . investments in research and development have yielded new products and solutions which is expected to generate sales growth in the future . 32 during 2016 , the company deployed cash in excess of $ 1.2 billion as it returned cash to shareholders through common share repurchases and dividend payments , as well as strengthened the business through acquisitions . during 2016 , the company completed two acquisitions with an aggregate purchase price of $ 341.1 million , including the acquisition of mis implants technologies ltd. ( “ mis ” ) , a manufacturer of dental implant systems , and a small acquisition of a healthcare consumable business . in addition , the company repurchased $ 813.9 million of common shares outstanding in 2016. company profile dentsply sirona is the world 's largest manufacturer of professional dental products and technologies , with a 130-year history of innovation and service to the dental industry and patients worldwide . dentsply sirona develops , manufactures , and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands . as the dental solutions company , dentsply sirona 's products provide innovative , high-quality and effective solutions to advance patient care and deliver better , safer and faster dentistry . dentsply sirona 's global headquarters is located in york , pennsylvania , and the international headquarters are based in salzburg , austria . the company 's shares are listed in the united states on nasdaq under the symbol xray . business the company operates in two business segments , dental and healthcare consumables and technologies . the dental and healthcare consumables segment includes responsibility for the worldwide design , manufacture , sales and distribution of the company 's dental and healthcare consumable products which include preventive , restorative , instruments , endodontic , and laboratory dental products as well as consumable medical device products . the technologies segment is responsible for the worldwide design , manufacture , sales and distribution of the company 's dental technology products which includes dental implants , cad/cam systems , imaging systems , treatment centers and orthodontic products . principal measurements the principal measurements used by the company in evaluating its business are : ( 1 ) constant currency sales growth by segment and geographic region ; ( 2 ) internal sales growth by segment and geographic region ; and ( 3 ) adjusted operating income and margins of each reportable segment , which excludes the impacts of purchase accounting , corporate expenses , and certain other items to enhance the comparability of results period to period . these principal measurements are not calculated in accordance with accounting principles generally accepted in the united states ; therefore , these items represent non-us gaap measures . these non-us gaap measures may differ from other companies and should not be considered in isolation from , or as a substitute for , measures of financial performance prepared in accordance with us gaap . the company defines “ constant currency ” sales growth as the increase or decrease in net sales from period to period excluding precious metal content and the impact of changes in foreign currency exchange rates . this impact is calculated by comparing current-period revenues to prior-period revenues , with both periods converted at the u.s. dollar to local currency average foreign exchange rate for each month of the prior period , for the currencies in which the company does business . the company defines “ internal ” sales growth as constant currency sales growth excluding the impacts of net acquisitions and divestitures , merger accounting impacts and discontinued products . business drivers the primary drivers of internal growth include macroeconomic factors , global dental market growth , innovation and new product launches by the company , as well as continued investments in sales and marketing resources , including clinical education . management believes that the company 's ability to execute its strategies has allowed it to grow faster than the underlying dental market . the company has a focus on maximizing operational efficiencies on a global basis . the company has expanded the use of technology as well as process improvement initiatives to enhance global efficiency . in addition , management continues to evaluate the consolidation of operations and functions , as part of integration activities , to further reduce costs . the company believes that the benefits from these global efficiency and integration initiatives will improve the cost structure and help mitigate the impacts of rising costs such as energy , employee benefits and regulatory oversight and compliance . 33 the company expects that it will record restructuring charges , from time to time , associated with such initiatives . these restructuring charges could be material to the company 's consolidated financial statements and there can be no assurance that the target adjusted operating income margins will continue to be achieved . in october 2016 , the company announced that it is proposing plans in germany to reorganize and combine portions of its manufacturing , logistics and distribution networks within both of the company 's segments . as required under german law , the company has entered into a statutory co-determination process under which it will collaborate with the appropriate labor groups to jointly define the infrastructure and staffing adjustments necessary to support this initiative . the company also initiated similar actions in other regions of the world . story_separator_special_tag the company also recorded $ 0.8 million of tax expense related to other discrete tax matters . excluding the impact of these tax matters , the company 's effective tax rate was 18.9 % . the effective tax rate was favorably impacted by the company 's change in the mix of consolidated earnings . further information regarding the details of income taxes is presented in note 14 , income taxes , in the notes to consolidated financial statements in item 15 of this form 10-k. the company 's effective income tax rate for 2016 included the net impact of business combination related costs and fair value adjustments , amortization of purchased intangible assets , restructuring program related costs and other costs , credit risk and fair value adjustments and income tax related adjustments which impacted income before income taxes and the provision for income taxes by $ 340.3 million and $ 153.1 million , respectively . the company 's effective income tax rate for 2015 included the net impact of restructuring program related costs and other costs , amortization of purchased intangible assets , business combination related costs and fair value adjustments , income tax related adjustments , credit risk and fair value adjustments and certain fair value adjustments related to an unconsolidated affiliated company which impacted income before income taxes and the provision for income taxes by $ 153.0 million and $ 33.5 million , respectively . 39 net income attributable to dentsply sirona in addition to the results reported in accordance with us gaap , the company provides adjusted net income attributable to dentsply sirona and adjusted earnings per diluted common share ( “ adjusted eps ” ) . the company discloses adjusted net income attributable to dentsply sirona to allow investors to evaluate the performance of the company 's operations exclusive of certain items that impact the comparability of results from period to period and may not be indicative of past or future performance of the normal operations of the company and certain large non-cash charges related to intangible assets either purchased or acquired through a business combination . the company believes that this information is helpful in understanding underlying operating trends and cash flow generation . adjusted net income and adjusted eps are important internal measures for the company . senior management receives a monthly analysis of operating results that includes adjusted net income and adjusted eps and the performance of the company is measured on this basis along with other performance metrics . the adjusted net income attributable to dentsply sirona consists of net income attributable to dentsply sirona adjusted to exclude the following : ( 1 ) business combination related costs and fair value adjustments . these adjustments include costs related to integrating and consummating mergers and recently acquired businesses , as well as costs , gains and losses related to the disposal of businesses or product lines . in addition , this category includes the roll off to the consolidated statement of operations of fair value adjustments related to business combinations , except for amortization expense noted below . these items are irregular in timing and as such may not be indicative of past and future performance of the company and are therefore excluded to allow investors to better understand underlying operating trends . ( 2 ) restructuring program related costs and other costs . these adjustments include costs related to the implementation of restructuring initiatives as well as certain other costs . these costs can include , but are not limited to , severance costs , facility closure costs , lease and contract terminations costs , related professional service costs , duplicate facility and labor costs associated with specific restructuring initiatives , as well as , legal settlements and impairments of assets . these items are irregular in timing , amount and impact to the company 's financial performance . as such , these items may not be indicative of past and future performance of the company and are therefore excluded for the purpose of understanding underlying operating trends . ( 3 ) amortization of purchased intangible assets . this adjustment excludes the periodic amortization expense related to purchased intangible assets . amortization expense has been excluded from adjusted net income attributed to dentsply sirona to allow investors to evaluate and understand operating trends excluding these large non-cash charges . ( 4 ) credit risk and fair value adjustments . these adjustments include both the cost and income impacts of adjustments in certain assets and liabilities including the company 's pension obligations , that are recorded through net income which are due solely to the changes in fair value and credit risk . these items can be variable and driven more by market conditions than the company 's operating performance . as such , these items may not be indicative of past and future performance of the company and therefore are excluded for comparability purposes . ( 5 ) certain fair value adjustments related to an unconsolidated affiliated company . this adjustment represents the fair value adjustment of the unconsolidated affiliated company 's convertible debt instrument held by the company . the affiliate is accounted for under the equity method of accounting . the fair value adjustment is driven by open market pricing of the affiliate 's equity instruments , which has a high degree of variability and may not be indicative of the operating performance of the affiliate or the company . ( 6 ) income tax related adjustments . these adjustments include both income tax expenses and income tax benefits that are representative of income tax adjustments mostly related to prior periods , as well as the final settlement of income tax audits , and discrete tax items resulting from the implementation of restructuring initiatives . these adjustments are irregular in timing and amount and may significantly impact the company 's operating performance . as such , these items may not be indicative of past and future performance of the

liquidity and capital resources cash flows from operating activities during the year ended december 31 , 2016 were $ 563.4 million compared to $ 497.4 million during the year ended december 31 , 2015. net income improved by $ 180.4 million in the period ended december 31 , 2016 compared to the prior year , largely from the merger and acquisition growth . this improvement was offset by increases in accounts receivable and prepaid expenses and merger transaction related fees and integration costs . working capital uses consumed $ 153.4 million in 2016 compared to cash generated of $ 65.4 million in 2015. primary working capital ( defined as inventories plus accounts receivable less accounts payable , a non-us gaap measure ) consumed $ 112.6 million of operating cash flow in 2016 compared to sources of $ 46.1 million in 2015. the investment of $ 112.6 million during the 2016 calendar year came from higher accounts receivable of $ 75.1 million , higher inventory of $ 11.6 million , and investment of $ 25.9 million in prepaid expenses and other current assets , net of accruals . this investment in primary working capital was partially offset by a reduction in inventory of $ 77.0 million related to the roll off of fair value adjustments from the merger and acquisitions . the decline in total working capital was further impacted by higher tax payments of $ 137.1 million in 2016 versus 2015. the company 's cash and cash equivalents increased by $ 99.3 million during the year ended december 31 , 2016 to $ 383.9 million .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```liquidity and capital resources cash flows from operating activities during the year ended december 31 , 2016 were $ 563.4 million compared to $ 497.4 million during the year ended december 31 , 2015. net income improved by $ 180.4 million in the period ended december 31 , 2016 compared to the prior year , largely from the merger and acquisition growth . this improvement was offset by increases in accounts receivable and prepaid expenses and merger transaction related fees and integration costs . working capital uses consumed $ 153.4 million in 2016 compared to cash generated of $ 65.4 million in 2015. primary working capital ( defined as inventories plus accounts receivable less accounts payable , a non-us gaap measure ) consumed $ 112.6 million of operating cash flow in 2016 compared to sources of $ 46.1 million in 2015. the investment of $ 112.6 million during the 2016 calendar year came from higher accounts receivable of $ 75.1 million , higher inventory of $ 11.6 million , and investment of $ 25.9 million in prepaid expenses and other current assets , net of accruals . this investment in primary working capital was partially offset by a reduction in inventory of $ 77.0 million related to the roll off of fair value adjustments from the merger and acquisitions . the decline in total working capital was further impacted by higher tax payments of $ 137.1 million in 2016 versus 2015. the company 's cash and cash equivalents increased by $ 99.3 million during the year ended december 31 , 2016 to $ 383.9 million .
```    
 Suspicious Activity Report : the company completed the elimination of certain corporate redundancies , the planning of country consolidation activities and the renegotiating of supply contracts with vendors . additionally , the company initiated reorganization activities that include manufacturing and logistics . the company achieved tax savings as it realized complementary tax attributes of the combined businesses . with regard to revenue synergies , dentsply sirona launched combined commercial activities , such as bundling products and developing cross-selling opportunities . investments in research and development have yielded new products and solutions which is expected to generate sales growth in the future . 32 during 2016 , the company deployed cash in excess of $ 1.2 billion as it returned cash to shareholders through common share repurchases and dividend payments , as well as strengthened the business through acquisitions . during 2016 , the company completed two acquisitions with an aggregate purchase price of $ 341.1 million , including the acquisition of mis implants technologies ltd. ( “ mis ” ) , a manufacturer of dental implant systems , and a small acquisition of a healthcare consumable business . in addition , the company repurchased $ 813.9 million of common shares outstanding in 2016. company profile dentsply sirona is the world 's largest manufacturer of professional dental products and technologies , with a 130-year history of innovation and service to the dental industry and patients worldwide . dentsply sirona develops , manufactures , and markets a comprehensive solutions offering including dental and oral health products as well as other consumable medical devices under a strong portfolio of world class brands . as the dental solutions company , dentsply sirona 's products provide innovative , high-quality and effective solutions to advance patient care and deliver better , safer and faster dentistry . dentsply sirona 's global headquarters is located in york , pennsylvania , and the international headquarters are based in salzburg , austria . the company 's shares are listed in the united states on nasdaq under the symbol xray . business the company operates in two business segments , dental and healthcare consumables and technologies . the dental and healthcare consumables segment includes responsibility for the worldwide design , manufacture , sales and distribution of the company 's dental and healthcare consumable products which include preventive , restorative , instruments , endodontic , and laboratory dental products as well as consumable medical device products . the technologies segment is responsible for the worldwide design , manufacture , sales and distribution of the company 's dental technology products which includes dental implants , cad/cam systems , imaging systems , treatment centers and orthodontic products . principal measurements the principal measurements used by the company in evaluating its business are : ( 1 ) constant currency sales growth by segment and geographic region ; ( 2 ) internal sales growth by segment and geographic region ; and ( 3 ) adjusted operating income and margins of each reportable segment , which excludes the impacts of purchase accounting , corporate expenses , and certain other items to enhance the comparability of results period to period . these principal measurements are not calculated in accordance with accounting principles generally accepted in the united states ; therefore , these items represent non-us gaap measures . these non-us gaap measures may differ from other companies and should not be considered in isolation from , or as a substitute for , measures of financial performance prepared in accordance with us gaap . the company defines “ constant currency ” sales growth as the increase or decrease in net sales from period to period excluding precious metal content and the impact of changes in foreign currency exchange rates . this impact is calculated by comparing current-period revenues to prior-period revenues , with both periods converted at the u.s. dollar to local currency average foreign exchange rate for each month of the prior period , for the currencies in which the company does business . the company defines “ internal ” sales growth as constant currency sales growth excluding the impacts of net acquisitions and divestitures , merger accounting impacts and discontinued products . business drivers the primary drivers of internal growth include macroeconomic factors , global dental market growth , innovation and new product launches by the company , as well as continued investments in sales and marketing resources , including clinical education . management believes that the company 's ability to execute its strategies has allowed it to grow faster than the underlying dental market . the company has a focus on maximizing operational efficiencies on a global basis . the company has expanded the use of technology as well as process improvement initiatives to enhance global efficiency . in addition , management continues to evaluate the consolidation of operations and functions , as part of integration activities , to further reduce costs . the company believes that the benefits from these global efficiency and integration initiatives will improve the cost structure and help mitigate the impacts of rising costs such as energy , employee benefits and regulatory oversight and compliance . 33 the company expects that it will record restructuring charges , from time to time , associated with such initiatives . these restructuring charges could be material to the company 's consolidated financial statements and there can be no assurance that the target adjusted operating income margins will continue to be achieved . in october 2016 , the company announced that it is proposing plans in germany to reorganize and combine portions of its manufacturing , logistics and distribution networks within both of the company 's segments . as required under german law , the company has entered into a statutory co-determination process under which it will collaborate with the appropriate labor groups to jointly define the infrastructure and staffing adjustments necessary to support this initiative . the company also initiated similar actions in other regions of the world . story_separator_special_tag the company also recorded $ 0.8 million of tax expense related to other discrete tax matters . excluding the impact of these tax matters , the company 's effective tax rate was 18.9 % . the effective tax rate was favorably impacted by the company 's change in the mix of consolidated earnings . further information regarding the details of income taxes is presented in note 14 , income taxes , in the notes to consolidated financial statements in item 15 of this form 10-k. the company 's effective income tax rate for 2016 included the net impact of business combination related costs and fair value adjustments , amortization of purchased intangible assets , restructuring program related costs and other costs , credit risk and fair value adjustments and income tax related adjustments which impacted income before income taxes and the provision for income taxes by $ 340.3 million and $ 153.1 million , respectively . the company 's effective income tax rate for 2015 included the net impact of restructuring program related costs and other costs , amortization of purchased intangible assets , business combination related costs and fair value adjustments , income tax related adjustments , credit risk and fair value adjustments and certain fair value adjustments related to an unconsolidated affiliated company which impacted income before income taxes and the provision for income taxes by $ 153.0 million and $ 33.5 million , respectively . 39 net income attributable to dentsply sirona in addition to the results reported in accordance with us gaap , the company provides adjusted net income attributable to dentsply sirona and adjusted earnings per diluted common share ( “ adjusted eps ” ) . the company discloses adjusted net income attributable to dentsply sirona to allow investors to evaluate the performance of the company 's operations exclusive of certain items that impact the comparability of results from period to period and may not be indicative of past or future performance of the normal operations of the company and certain large non-cash charges related to intangible assets either purchased or acquired through a business combination . the company believes that this information is helpful in understanding underlying operating trends and cash flow generation . adjusted net income and adjusted eps are important internal measures for the company . senior management receives a monthly analysis of operating results that includes adjusted net income and adjusted eps and the performance of the company is measured on this basis along with other performance metrics . the adjusted net income attributable to dentsply sirona consists of net income attributable to dentsply sirona adjusted to exclude the following : ( 1 ) business combination related costs and fair value adjustments . these adjustments include costs related to integrating and consummating mergers and recently acquired businesses , as well as costs , gains and losses related to the disposal of businesses or product lines . in addition , this category includes the roll off to the consolidated statement of operations of fair value adjustments related to business combinations , except for amortization expense noted below . these items are irregular in timing and as such may not be indicative of past and future performance of the company and are therefore excluded to allow investors to better understand underlying operating trends . ( 2 ) restructuring program related costs and other costs . these adjustments include costs related to the implementation of restructuring initiatives as well as certain other costs . these costs can include , but are not limited to , severance costs , facility closure costs , lease and contract terminations costs , related professional service costs , duplicate facility and labor costs associated with specific restructuring initiatives , as well as , legal settlements and impairments of assets . these items are irregular in timing , amount and impact to the company 's financial performance . as such , these items may not be indicative of past and future performance of the company and are therefore excluded for the purpose of understanding underlying operating trends . ( 3 ) amortization of purchased intangible assets . this adjustment excludes the periodic amortization expense related to purchased intangible assets . amortization expense has been excluded from adjusted net income attributed to dentsply sirona to allow investors to evaluate and understand operating trends excluding these large non-cash charges . ( 4 ) credit risk and fair value adjustments . these adjustments include both the cost and income impacts of adjustments in certain assets and liabilities including the company 's pension obligations , that are recorded through net income which are due solely to the changes in fair value and credit risk . these items can be variable and driven more by market conditions than the company 's operating performance . as such , these items may not be indicative of past and future performance of the company and therefore are excluded for comparability purposes . ( 5 ) certain fair value adjustments related to an unconsolidated affiliated company . this adjustment represents the fair value adjustment of the unconsolidated affiliated company 's convertible debt instrument held by the company . the affiliate is accounted for under the equity method of accounting . the fair value adjustment is driven by open market pricing of the affiliate 's equity instruments , which has a high degree of variability and may not be indicative of the operating performance of the affiliate or the company . ( 6 ) income tax related adjustments . these adjustments include both income tax expenses and income tax benefits that are representative of income tax adjustments mostly related to prior periods , as well as the final settlement of income tax audits , and discrete tax items resulting from the implementation of restructuring initiatives . these adjustments are irregular in timing and amount and may significantly impact the company 's operating performance . as such , these items may not be indicative of past and future performance of the

